Ultragenyx Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Ultragenyx
RARE Stock  USD 22.75  0.24  1.07%   
Ultragenyx's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ultragenyx's valuation are provided below:
Gross Profit
-186 M
Profit Margin
(0.85)
Market Capitalization
2.2 B
Enterprise Value Revenue
4.1576
Revenue
673 M
There are over one hundred nineteen available fundamental trend indicators for Ultragenyx, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Ultragenyx's current performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of February 25, 2026, Market Cap is expected to decline to about 2.4 B. In addition to that, Enterprise Value is expected to decline to about 2.3 B

Ultragenyx Total Revenue

706.65 Million

Check Ultragenyx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultragenyx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.8 M, Interest Expense of 65.1 M or Selling General Administrative of 388.3 M, as well as many indicators such as Price To Sales Ratio of 3.2, Dividend Yield of 0.0028 or Days Sales Outstanding of 154. Ultragenyx financial statements analysis is a perfect complement when working with Ultragenyx Valuation or Volatility modules.
  
Build AI portfolio with Ultragenyx Stock
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Ultragenyx Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets964.9 M1.5 B831.5 M
Slightly volatile
Other Current Liabilities285.6 M272 M107.9 M
Slightly volatile
Total Current Liabilities403.2 M384 M141.5 M
Slightly volatile
Other Liabilities1.1 B1 B357.6 M
Slightly volatile
Property Plant And Equipment Net280.4 M267 M106 M
Slightly volatile
Accounts Payable17.3 M31 M14.9 M
Slightly volatile
Cash220.5 M434 M190.4 M
Slightly volatile
Non Current Assets Total345.8 M581 M297.8 M
Slightly volatile
Other Assets20.3 M19.4 M8.4 M
Slightly volatile
Cash And Short Term Investments535.5 M693 M461.7 M
Slightly volatile
Net Receivables166.9 M159 M40.6 M
Slightly volatile
Common Stock Total Equity44.1 K80.5 K44 K
Slightly volatile
Common Stock Shares Outstanding58 M98.6 M51.3 M
Slightly volatile
Liabilities And Stockholders Equity964.9 M1.5 B831.5 M
Slightly volatile
Non Current Liabilities Total1.3 B1.2 B386.1 M
Slightly volatile
Other Current Assets37.1 M47 M31.9 M
Slightly volatile
Other Stockholder Equity4.7 B4.4 B1.9 B
Slightly volatile
Total Liabilities1.7 B1.6 B527.6 M
Slightly volatile
Property Plant And Equipment Gross456.9 M435.2 M146 M
Slightly volatile
Total Current Assets619.1 M951 M533.7 M
Slightly volatile
Common Stock111.1 K105.8 K51.5 K
Slightly volatile
Property Plant Equipment313.6 M298.7 M103.2 M
Slightly volatile
Short Term Investments352.7 M259 M274 M
Slightly volatile
Net Tangible Assets161.7 M170.2 M326.8 M
Very volatile
Capital Surpluse2 B3.6 B1.7 B
Slightly volatile
Non Current Liabilities Other18.7 M19.6 M70.8 M
Pretty Stable
Current Deferred Revenue237.3 M226 M64.2 M
Slightly volatile
Net Invested Capital218.3 M229.8 M455.2 M
Very volatile
Net Working Capital649.3 M543.9 M429.7 M
Slightly volatile
Capital Stock76.8 K105.8 K63.5 K
Slightly volatile
Short and Long Term Debt Total1.3 B1.3 B187.7 M
Slightly volatile
Capital Lease Obligations32.3 M36.3 M37.9 M
Very volatile
Short Term Debt85 M81 M17.2 M
Slightly volatile

Ultragenyx Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization36.8 M35 M12.8 M
Slightly volatile
Selling General Administrative388.3 M369.9 M151.8 M
Slightly volatile
Other Operating Expenses1.3 B1.2 B512.9 M
Slightly volatile
Research Development787.5 M750 M339.7 M
Slightly volatile
Total Operating Expenses1.2 B1.1 B489 M
Slightly volatile
Interest Income44.1 M42 M13.1 M
Slightly volatile
Reconciled Depreciation42.9 M40.9 M15.5 M
Slightly volatile

Ultragenyx Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation79 M153 M68.1 M
Slightly volatile
Begin Period Cash Flow191.8 M184.2 M165.1 M
Slightly volatile
Other Cashflows From Financing Activities501.9 M478 M128.4 M
Slightly volatile
Depreciation42.9 M40.9 M13.5 M
Slightly volatile
Capital Expenditures5.7 M6 M22.4 M
Slightly volatile
Total Cash From Financing Activities332.6 M478 M287.4 M
Slightly volatile
End Period Cash Flow223.6 M436 M193.1 M
Slightly volatile
Sale Purchase Of Stock9.2 M9.7 M170.5 M
Slightly volatile
Issuance Of Capital Stock196.3 M342.9 M278.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.23.36978.7 K
Slightly volatile
Dividend Yield0.00280.00310.0034
Slightly volatile
Days Sales Outstanding15486.2333381
Slightly volatile
Stock Based Compensation To Revenue0.220.2273151
Slightly volatile
Capex To Depreciation0.230.244.0901
Slightly volatile
EV To Sales4.394.62088.2 K
Slightly volatile
Inventory Turnover2.22.09620.6352
Slightly volatile
Days Of Inventory On Hand1651741.4 K
Slightly volatile
Payables Turnover4.43.51612.9884
Very volatile
Sales General And Administrative To Revenue2.712.85205
Slightly volatile
Research And Ddevelopement To Revenue1.061.1144574
Slightly volatile
Capex To Revenue0.00850.008931.677
Slightly volatile
Cash Per Share6.677.02847.7796
Slightly volatile
Days Payables Outstanding98.62104909
Pretty Stable
Income Quality0.890.81040.8151
Very volatile
Intangibles To Total Assets0.190.14360.2586
Slightly volatile
Current Ratio2.352.47668.3037
Slightly volatile
Receivables Turnover4.944.23273.7652
Slightly volatile
Capex Per Share0.05780.06090.3464
Slightly volatile
Revenue Per Share7.176.82562.5809
Slightly volatile
Interest Debt Per Share14.2513.572.313
Slightly volatile
Debt To Assets0.870.83290.1271
Slightly volatile
Operating Cycle247260130.7 K
Slightly volatile
Days Of Payables Outstanding98.62104909
Pretty Stable
Ebt Per Ebit0.781.06730.9689
Pretty Stable
Long Term Debt To Capitalization0.860.971.0547
Slightly volatile
Total Debt To Capitalization1.121.06690.1859
Slightly volatile
Quick Ratio2.222.34118.2452
Slightly volatile
Net Income Per E B T0.81.0070.9873
Slightly volatile
Cash Ratio1.071.13024.3609
Slightly volatile
Days Of Inventory Outstanding1651741.4 K
Slightly volatile
Days Of Sales Outstanding15486.2333381
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.881.01291.0874
Very volatile
Fixed Asset Turnover1.282.52061.0179
Slightly volatile
Debt Ratio0.870.83290.1271
Slightly volatile
Price Sales Ratio3.23.36978.7 K
Slightly volatile
Asset Turnover0.460.43930.1384
Slightly volatile

Ultragenyx Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B3.4 B2.9 B
Slightly volatile
Enterprise Value2.3 B3.3 B2.8 B
Slightly volatile

Ultragenyx Fundamental Market Drivers

Ultragenyx Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ultragenyx Financial Statements

Ultragenyx stakeholders use historical fundamental indicators, such as Ultragenyx's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ultragenyx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ultragenyx's assets and liabilities are reflected in the revenues and expenses on Ultragenyx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ultragenyx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue226 M237.3 M
Total Revenue673 M706.6 M
Cost Of Revenue109 M114.5 M
Stock Based Compensation To Revenue 0.23  0.22 
Sales General And Administrative To Revenue 2.85  2.71 
Research And Ddevelopement To Revenue 1.11  1.06 
Capex To Revenue 0.01  0.01 
Revenue Per Share 6.83  7.17 
Ebit Per Revenue(0.79)(0.83)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
How To Invest In Ultragenyx
Details
Is Ultragenyx Stock a good investment?
Details
What is Ultragenyx's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could Ultragenyx diversify its offerings? Factors like these will boost the valuation of Ultragenyx. Anticipated expansion of Ultragenyx directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ultragenyx data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(5.83)
Revenue Per Share
6.826
Quarterly Revenue Growth
0.259
Return On Assets
(0.22)
Return On Equity
(6.08)
Understanding Ultragenyx requires distinguishing between market price and book value, where the latter reflects Ultragenyx's accounting equity. The concept of intrinsic value - what Ultragenyx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Ultragenyx's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Ultragenyx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ultragenyx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ultragenyx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY